Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.


Clinical Trial Description

The study is being conducted in order to obtain safety, efficacy and tolerability data for Clobetasol propionate foam in the treatment of chronic dermatitis. The subjects must have mild to moderate disease based on the Investigator's assessment at baseline. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00828464
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 4
Start date October 2008
Completion date January 2009

See also
  Status Clinical Trial Phase
Completed NCT00843466 - Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis N/A